Skip to main content
Top

Herpesviridae

Issue 1/2010

Content (8 Articles)

Open Access Editorial

Welcome to Herpesviridae — a new premier virology journal

Mensur Dzabic, Robert Hendricks, Christian Münz, Cecilia Söderberg-Nauclér

Open Access Research

HCMV pUS28 initiates pro-migratory signaling via activation of Pyk2 kinase

Jennifer Vomaske, Susan Varnum, Ryan Melnychuk, Patricia Smith, Ljiljana Pasa-Tolic, Janani I Shutthanandan, Daniel N Streblow

Open Access Short Report

Simultaneous quantification of human herpesvirus 8 DNA by real time PCR in different tissues of HIV infected cuban patients with Kaposi's sarcoma

Vivian Kourí, Pedro A Martínez, Orestes Blanco, Virginia Capó, María E Rodríguez, María del C Dovigny, Lidia Cardellá, Angela Gala, Narciso A Jiménez, Consuelo Correa, Yoan Alemán, Lissette Pérez, Alina Álvarez, Ulrich Hengge

Open Access Research

Chromosomal integration of an avian oncogenic herpesvirus reveals telomeric preferences and evidence for lymphoma clonality

Charmaine M Robinson, Henry D Hunt, Hans H Cheng, Mary E Delany

Open Access Review

Epstein-Barr virus genetics: talking about the BAC generation

Regina Feederle, Emmalene J Bartlett, Henri-Jacques Delecluse

Open Access Research

RCMV increases intimal hyperplasia by inducing inflammation, MCP-1 expression and recruitment of adventitial cells to intima

Monika K Grudzinska, Krzysztof Bojakowski, Joanna Soin, Frank Stassen, Cecilia Söderberg-Nauclér, Piotr Religa

Open Access Research

Detection of human cytomegalovirus in normal and neoplastic breast epithelium

Lualhati E Harkins, Lisa A Matlaf, Liliana Soroceanu, Katrin Klemm, William J Britt, Wenquan Wang, Kirby I Bland, Charles S Cobbs

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine